1.Date of occurrence of the event:2016/12/17 2.Counterparty to the contract or commitment:Pharmally International Holding Co., Ltd and Mottama Holdings Ltd. 3.Relationship to the Company:Unrelated 4.Starting and ending dates (or rescission date) of the contract or commitment:2016/12/17 5.Major content (not applicable where rescinded): SCCPC has agreed to jointly invest in pharmaceutical industries in Myanmar with Pharmally International Holding Co., Ltd and Mottama Holdings Ltd. The letter of intent merely declares intent for collaboration and all details with regard to the collaboration shall be subject to the final contract to be signed. 6.Restrictive covenants (not applicable where rescinded): In accordance with the letter of intent. 7.Effect on company finances and business (not applicable where rescinded): The collaboration helps SCCPC develop new market in Myanmar, speed up arrangement in ASEAN, improve competitiveness, and put Internationalization Strategy into action. 8.Concrete purpose/objective (not applicable where rescinded): To co-invest with Pharmally International Holding Co., Ltd and Mottama Holdings Ltd., and set up a production line of Large Volume Parenteral in collaboration with BPI, which is affiliated with Myanmar Industries Association, to meet market demand in Myanmar. 9.Any other matters that need to be specified:None